Most patients report craving less food and stopping at smaller portions
However, in the case of cardiovascular indications, Wegovy seems to have the upper hand, as Zepbound hasnt demonstrated cardiovascular benefit yet
Sleep, stress, energy and confidence may all shift at the same time
As of January 28, 2025, the FDA has approved Ozempic for 3 uses: Improve blood sugar levels in adults with type 2 diabetes Reduce the risk of major cardiovascular events (heart attack, stroke, or death) in adults with type 2 diabetes and known heart disease Reduce the risk of kidney disease progression and cardiovascular death in adults with type 2 diabetes and chronic kidney disease While Ozempic can lead to weight loss at higher doses, it has not been approved as a weight loss medication
These actions lead to improved muscle integrity and faster recovery times, attracting attention in regenerative performance and rehabilitation research
Consult a licensed medical provider before beginning any peptide therapy